USPTO 2015–2025 USPTO PatentsView US Corporation

Watson Laboratories Inc.

USPTO PatentsView assignee record - 8 granted patents across 6 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company

The verdict

According to USPTO PatentsView, Watson ranks #33,868 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 6 technology areas.

#33,868
of 49,997 US assignees by volume
29th percentile
by Innovation Score (29.0/100)
21.3
avg claims per patent
-40%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R33868 · US Corporation #33,868 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-MICRO 8 grants
  • MID-PACK #33,868/49,997
  • PHOTO-FINISH Volution Immuno…
  • CPC-NARROW A61P · 6 areas
  • INNOV-THIN 29.0/100
  • CLAIMS-DENSE 21.3 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DOWN -40% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Volution Immuno Pharmaceuticals SA (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Watson

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Watson's Innovation Score is 29.0/100 (29th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Watson's grants concentrate

Watson Laboratories Inc. is a focused PatentsView assignee: 6 CPC subclasses with 50% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (4 grants) versus a trough of 1 in 2016. By volume, Watson sits between Volution Immuno Pharmaceuticals SA and Well Shin Technology Co., Ltd..

Who files at Watson's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Watson holds 8 patents at rank #33,844, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Watson

By rank, the assignees closest to #33,844 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Watson's primary technology class.

Watson's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 29th percentile higher than 29% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 201520162021 3
USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Watson Laboratories Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 4 50.0%
2016 1 12.5%
2021 3 37.5%

Where it ranks

Overall rank by patents

#33,868

of 49,997 tracked assignees

Innovation Score

29.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Watson Laboratories Inc.'s patent record in context - here's where to go next.

  • Watson Laboratories Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 50% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #33,868 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Watson Laboratories Inc. against Volution Immuno Pharmaceuticals SA, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 29.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.